Journal of the American Society of Nephrology (JASN) podkast

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

0:00
21:23
Do tyłu o 15 sekund
Do przodu o 15 sekund
Dr. Briggs and Brendon Neuen discuss his paper in the December issue of JASN. This article on the CREDENCE and EMPA-CKD clinical trials shows that SGLT2 inhibitors allow more consistent use of RAS blockade in patients with declining renal function.

Więcej odcinków z kanału "Journal of the American Society of Nephrology (JASN)"